Abbott MediaRoom http://abbott.mediaroom.com/ Abbott Hosts Conference Call for First-Quarter Earnings http://abbott.mediaroom.com/2017-03-22-Abbott-Hosts-Conference-Call-for-First-Quarter-Earnings Wed, 22 Mar 2017 09:00:00 -0400 http://abbott.mediaroom.com/2017-03-22-Abbott-Hosts-Conference-Call-for-First-Quarter-Earnings Late-Breaking Data Shows the CardioMEMS HF System is Effective in Reducing Heart Failure Hospitalizations and Cost of Care http://abbott.mediaroom.com/2017-03-19-Late-Breaking-Data-Shows-the-CardioMEMS-HF-System-is-Effective-in-Reducing-Heart-Failure-Hospitalizations-and-Cost-of-Care - Presented at ACC and published in Journal of American College of Cardiology, the CardioMEMS™ HF System offers sustained benefits for patients suffering from symptomatic heart failure Sun, 19 Mar 2017 14:00:00 -0400 http://abbott.mediaroom.com/2017-03-19-Late-Breaking-Data-Shows-the-CardioMEMS-HF-System-is-Effective-in-Reducing-Heart-Failure-Hospitalizations-and-Cost-of-Care Late-Breaking Data on Abbott's MitraClip® System Show Continued Benefit for People with Mitral Regurgitation, Most Common Heart Valve Disease http://abbott.mediaroom.com/2017-03-18-Late-Breaking-Data-on-Abbotts-MitraClip-R-System-Show-Continued-Benefit-for-People-with-Mitral-Regurgitation-Most-Common-Heart-Valve-Disease - 92.8% procedural success observed in reducing leaky heart valve Sat, 18 Mar 2017 12:30:00 -0400 http://abbott.mediaroom.com/2017-03-18-Late-Breaking-Data-on-Abbotts-MitraClip-R-System-Show-Continued-Benefit-for-People-with-Mitral-Regurgitation-Most-Common-Heart-Valve-Disease Data on Absorb Bioresorbable Stent Show Comparable Outcomes to Leading Drug-Eluting Stent Between One and Two Years http://abbott.mediaroom.com/2017-03-18-Data-on-Absorb-Bioresorbable-Stent-Show-Comparable-Outcomes-to-Leading-Drug-Eluting-Stent-Between-One-and-Two-Years - Results emphasize importance of proper vessel sizing and following current instructions for use for optimal clinical outcomes Sat, 18 Mar 2017 10:45:00 -0400 http://abbott.mediaroom.com/2017-03-18-Data-on-Absorb-Bioresorbable-Stent-Show-Comparable-Outcomes-to-Leading-Drug-Eluting-Stent-Between-One-and-Two-Years Abbott to Present at Barclays Capital 2017 Global Healthcare Conference http://abbott.mediaroom.com/2017-03-08-Abbott-to-Present-at-Barclays-Capital-2017-Global-Healthcare-Conference Wed, 08 Mar 2017 16:15:00 -0500 http://abbott.mediaroom.com/2017-03-08-Abbott-to-Present-at-Barclays-Capital-2017-Global-Healthcare-Conference